Clinical Trial Update: AdvisaTM IPG Clinical Evaluation Study [NA]

View source ↗

Summary

A completed clinical evaluation study of the Advisa IPG (implantable pacemaker) sponsored by Medtronic for bradycardia and atrial tachyarrhythmia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Tachyarrhythmia
• Bradycardia

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Bradycardia, Atrial Tachyarrhythmia | NA | Status: COMPLETED